Correlation between selenoprotein S and physiological indicators in patients with type 2 diabetes mellitus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055375

Enrollment

Unknown

Registered

2022-01-08

Start date

2021-12-01

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

T2DM group:None

Non-T2DM group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as type 2 diabetes mellitus (T2DM); 2. Those who have a normal physical examination in the physical examination center.

Exclusion criteria

Exclusion criteria: 1. Diabetic-related acute complications such as diabetic hyperosmolar coma or diabetic ketoacidosis have occurred within the past 3 months; 2. Has recently suffered from severe infection, surgery or trauma and other stress states, or is in a special physical period such as pregnancy or breastfeeding, or aged < 18 years; 3. History of severe liver function damage, cardiovascular and cerebrovascular diseases, infectious diseases or malignant tumors.

Design outcomes

Primary

Measure	Time frame
serum selenoprotein S;	—

Secondary

Measure	Time frame
fasting blood glucose;2h blood glucose;ISI;HbA1c;TG;TC;LDL-C;HDL-C;ALT;AST;GGT;ALB;ALP;urinary albumin;blood urea nitrogen;urine creatinine;blood uric acid;HOMA-IR;	—

Countries

China

Contacts

Public ContactChe Bian

The Fourth Affiliated Hospital of China Medical University

bianche1028@163.com+86 18900912240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026